MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Benefits of Recreational Therapy and Speech Therapy among Participants with Parkinson’s Disease: Findings from a 12-month study

    S. Parveen, B. Brickell, C. Romoser, H. Wilson, T. Passmore, M. Bateman (Stillwater, OK, USA)

    Objective: The current study reports findings from a year-long community-based multidisciplinary program for individuals with Parkinson's disease (PD). Background: Parkinson's disease is a multimodality disorder…
  • MDS Virtual Congress 2020

    The Accreditation and Certification of the Movement Disorders Subspecialty: A Five-Year Follow-Up Study

    S. O'Shea, L. Gutmann, L. Faulkner (Boston, MA, USA)

    Objective: The purpose of our study was to assess if sentiments regarding the accreditation and certification of Movement Disorders Fellowships have changed over the past…
  • MDS Virtual Congress 2020

    Movement disorders in a family carrying ATP7A variant

    G. Buongarzone, B. Minafra, E. Errichiello, S. Gana, A. Asaro, I. Canavero, E. Tartara, M. Paoletti, R. Zangaglia, C. Cereda, C. Pacchetti, E.M Valente (Pavia, Italy)

    Objective: To report an early onset parkinsonism in a family carrying a pathogenic variant in the ATP7A gene. Background: ATP7A variants cause Menkes disease (MD), a…
  • MDS Virtual Congress 2020

    Long-term effect of non-invasive Vagus Nerve Stimulation in Parkinson’s disease patients

    H. Kumar, B. Mondal, S. Choudhury, R. Banerjee, A. Roy, K. Chatterjee, P. Basu, S. Baker, M. Baker (Kolkata, India)

    Objective: In this first ever, randomized, double-blind control trial we explored the role of noninvasive VNS (nVNS) in the treatment of gait and motor symptoms…
  • MDS Virtual Congress 2020

    Confrontation Naming Deficit in Lewy Body Dementia Patients with Alzheimer’s Disease Co-Pathology

    E. Howard, D. Irwin, K. Rascovsky, N. Nevler, S. Shellikeri, D. Mechanic-Hamilton, T. Tropea, A. Chen-Plotkin, A. Siderowf, D. Weintraub, L. Shaw, J. Trojanowski, M. Grossman, K. Cousins (Philadelphia, PA, USA)

    Objective: To test the association between confrontation naming performance and Alzheimer’s disease (AD) co-pathology as defined by cerebrospinal fluid (CSF) biomarkers in Lewy body dementia…
  • MDS Virtual Congress 2020

    Comparative analysis of cognitive function between unilaterally and bilaterally affected Parkinson’s disease

    J. Lee, G.S Kim (Goyang-si, Republic of Korea)

    Objective: To compare the cognitive function between unilateral and bilateral PD to identify whether worse cognitive impairment underlies in the bilateral group who had greater…
  • MDS Virtual Congress 2020

    Investigating Factors Contributing to Parkinson’s disease-related Cognitive Decline

    P. Tipton, N. Bulbul, J. Crook, O. Ross, Z. Wszolek, N. Ertekin-taner (Jacksonville, FL, USA)

    Objective: The objective of this study was to identify predictive factors of cognitive decline in patients with Parkinson’s disease (PD). Background: Among those with PD,…
  • MDS Virtual Congress 2020

    NUS1 polymorphisms modify the risk and age at onset of Parkinson’s disease

    L. Jiang, J. Mei, Y. Zhao, R. Zhang, H. Pan, Y. Yang, Q. Sun, Q. Xu, X. Yan, J. Tan, J. Li, B. Tang, J. Guo (Changsha, China)

    Objective: In this study, using whole-exome sequencing (WES) and direct Sanger sequencing analysis, we investigated the common and low-frequency variants of NUS1 in two case-control…
  • MDS Virtual Congress 2020

    Interest of multiplex ligation-dependent probe amplification assay to identify pathogenic mutations in Parkinson’s disease patients

    E. Mutez, M. Swiderski, L. Defebvre, M.C Chartier-Harlin, V. Huin (Lille, France)

    Objective: To evaluate the interest of the MLPA (Multiplex Ligation-dependent Probe Amplification) commercially available kit in the genetic testing in Parkinson’s disease (PD). Background: PD…
  • MDS Virtual Congress 2020

    Screening of mutations in PARK2 gene and Dopamine levels in Parkinson’s disease (PD) patients in Coimbatore population, India

    I. Iyer, V. Venkatesan, V. Vellingiri (Coimbatore, India)

    Objective: The aim of the present study was to perform the mutational screening of PARK2 gene and dopamine level in PD patients of Coimbatore population,…
  • « Previous Page
  • 1
  • …
  • 105
  • 106
  • 107
  • 108
  • 109
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #23660 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley